Multi-center Study Focuses On Drug Therapy to Stabilize Bleeding after TBI

Tags: , , ,

A multi-center national clinical trial will focus on determining if a new intravenous drug therapy can improve outcomes for patients who have life-threatening or life-altering traumatic brain injury (TBI). The drug, Tranexamic Acid (TXA), prevents the breakdown of blood clots and is already used to control bleeding for many conditions. 

Click here to read the full article.

There are no comments published yet.

Change this in Theme Options
Change this in Theme Options